Nuveen Asset Management, LLC Uro Gen Pharma Ltd. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 92,957 shares of URGN stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,957

Previous 149,387 37.77%

Holding current value

$1.61 Million

Previous $1.9 Million 47.87%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.52 - $13.11 $593,643 - $739,797	-56,430 Reduced 37.77%	92,957 $989,000
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $716,661 - $1.01 Million	56,430 Added 60.71%	149,387 $1.9 Million
Q2 2024 Aug 09, 2024	BUY	$12.72 - $19.2 $121,323 - $183,129	9,538 Added 11.43%	92,957 $1.56 Million
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $215,062 - $315,175	19,785 Added 31.09%	83,419 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $19,200 - $49,174	2,172 Added 3.53%	63,634 $891,000
Q2 2023 Aug 14, 2023	BUY	$8.75 - $14.29 $537,792 - $878,291	61,462 New	61,462 $636,000
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $484,659 - $827,328	-94,660 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $5,375 - $8,834	908 Added 0.97%	94,660 $854,000
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $59,272 - $125,569	-6,564 Reduced 6.54%	93,752 $906,000
Q3 2021 Nov 12, 2021	BUY	$14.31 - $18.39 $53,175 - $68,337	3,716 Added 3.85%	100,316 $1.67 Million
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $92,020 - $126,770	-6,054 Reduced 5.9%	96,600 $1.48 Million
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $1.71 Million - $2.56 Million	-95,036 Reduced 48.07%	102,654 $2 Million
Q4 2020 Feb 16, 2021	SELL	$17.54 - $25.43 $746,467 - $1.08 Million	-42,558 Reduced 17.71%	197,690 $3.56 Million
Q3 2020 Nov 16, 2020	SELL	$18.81 - $26.42 $1.82 Million - $2.56 Million	-96,901 Reduced 28.74%	240,248 $4.64 Million
Q2 2020 Aug 14, 2020	BUY	$16.5 - $29.7 $1.09 Million - $1.97 Million	66,316 Added 24.49%	337,149 $8.81 Million
Q1 2020 May 14, 2020	BUY	$13.68 - $34.6 $3.7 Million - $9.37 Million	270,833 New	270,833 $4.83 Million
Q4 2019 Feb 14, 2020	SELL	$21.11 - $34.86 $959,322 - $1.58 Million	-45,444 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $62,386 - $95,399	2,618 Added 6.11%	45,444 $1.08 Million
Q2 2019 Aug 15, 2019	BUY	$32.75 - $40.35 $1.4 Million - $1.73 Million	42,826 New	42,826 $1.54 Million

Others Institutions Holding URGN

# of Institutions

161

Shares Held

39.6M

Call Options Held

2.06M

Put Options Held

717K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $393M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Uro Gen Pharma Ltd. Transaction History